Chris Abbott-backed Genetic Signatures tipped to raise $30m
SYDNEY: Listed molecular diagnostics biotech Genetic Signatures had secured interest for a $30 ... read more
Telix to raise $300m and set to list on Nasdaq
MELBOURNE: Telix Pharmaceuticals, the developer of cancer treatments and a favourite of local ... read more
ACCC overstates chemist merger risks claims Barrenjoey
MELBOURNE: The competition regulator entirely ignored a major wholesaler when it warned that ... read more
Telix pulls $300m Nasdaq IPO as investors demand deep discount
MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 ... read more
